David R. Bauer
Lawyers
Filters
Amulet Capital Partners sale of SSI Strategy to Clinigen
We are advising Amulet Capital Partners and SSI Strategy on the sale
Medtronic €1.5 billion notes offering
The investment-grade notes are due 2030 and 2045
MBX Biosciences $200 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Oscar Health $410 million convertible senior subordinated notes and capped call transactions
The 2.25% convertible notes are due 2030
Bruker mandatory convertible preferred stock offering
The preferred stock will be listed on Nasdaq
Precigen $125 million financing
We advised Precigen on the loan agreement
Eli Lilly $6.75 billion notes offering
The investment-grade offering consisted of seven tranches
Zoetis $1.85 billion senior notes offering
The investment-grade notes are due 2028 and 2035
Cloud Software Group $1 billion notes offering
The high-yield notes are due 2033
Tempus AI $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market